Ridogrel (Synonyms: R 68070)
目录号: PL10099 纯度: ≥99%
CAS No. :110140-89-1
商品编号 规格 价格 会员价 是否有货 数量
PL10099-5mg 5mg ¥4982.00 请登录
PL10099-10mg 10mg 询价 询价
PL10099-50mg 50mg 询价 询价
PL10099-10mM*1mLinDMSO 10mM*1mLinDMSO ¥5480.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Ridogrel
中文别名
利多格雷
英文名称
Ridogrel
英文别名
RIDOGREL;R-68070;5-[[(E)-(3-Pyridinyl)[3-(trifluoromethyl)phenyl]methylene]aminooxy]valeric acid;5-[[[(E)-α-(Pyridine-3-yl)-3-(trifluoromethyl)benzylidene]amino]oxy]valeric acid;5-[[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypenta noic acid;Pentanoic acid, 5-[[(E)-[3-pyridinyl[3-(trifluoromethyl)phenyl]methylene]amino]oxy]-;Ridogrel
Cas No.
110140-89-1
分子式
C18H17N2O3F3
分子量
366.33
包装储存
Powder -20°C 3 years;In solvent -80°C 6 months
产品详情
Ridogrel (R 68070) 是一种口服活性的血栓素 A2 合成酶 (combined thromboxane A2 synthetase) 抑制剂和血栓素 A2/前列腺素内过氧化物受体 (thromboxane A2/prostaglandin endoperoxide receptor) 阻滞剂。Ridogrel 是一种有效的抗血小板剂,具有抗炎活性。
生物活性
Ridogrel (R 68070) is an orally active combined thromboxane A2 synthetase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor blocker. Ridogrel is potent antiplatelet agent. Anti-inflammatory activities.
性状
Solid
体外研究(In Vitro)
In rats, R 68 070 (1.25 mg/kg orally, -2 h) singly prolongs tail bleeding times as much as a combination of TXA2 synthetase inhibition (dazoxiben 10 mg/kg) and TXA2/prostaglandin endoperoxide receptor blockade (BM 13177 40 mg/kg). In dogs, the compound reduces coronary thrombosis induced by electrical damage (1.25 mg/kg i.v.) and prevents the evolution of occlusion/reperfusion-induced arrhythmias into ventricular fibrillation (2.5 mg/kg i.v.). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;In solvent -80°C 6 months
参考文献
[1]. De Clerck F, et al. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo. Thromb Haemost. 1989;61(1):43-49.
[2]. Di Perri T, et al. Ridogrel, una nuova molecula antiaggregante piastrinica a doppio meccanismo dazione. Profilo farmacologico e clinico [Ridogrel, a new platelet antiaggregant molecule with a double mechanism of action. A pharmacological and clinical pro
溶解度数据
In Vitro: DMSO : 100 mg/mL (272.98 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2